「with the」の検索結果
93件：11～15件目を表示
-
nju is committed to obtaining marketing approval for the DED treatment SJP-0132 to provide patients with new options for alleviating the signs and symptoms of this disease. Mochida is dedicated to lev...
https://www.senju.co.jp/system/files/content_news/2025-01/ENG_20250117.pdf -
arpening algorithm. We aim to promote “more visibility” by providing products and services equipped with image sharpening and high-resolution algorithms in the future, emphasizing the importance of si...
https://www.senju.co.jp/system/files/content_news/2024-04/ENG_20240423.pdf -
发表论文 | 研究与开发 | 千寿制药株式会社
愛媛大学医学部眼科学教室 2)千寿製薬株式会社 3)日野病院 あたらしい眼科42(12)：1566～1576 Efficacy and Safety of SJP-0132 in Patients with Dry Eye Disease: A Phase 2b Randomized, Double-Masked, Dose-Finding Study Yuichi Hori1, Tomoyuk...
http://www.senju.co.jp/chinese/rd/thesis/ -
学会発表実績 | 研究開発活動 | 千寿製薬株式会社
開催地：Salt Lake City, Utah, United States of America Establishment of in vitro drug evaluation model with retinal ganglion cells from Leber’s hereditary optic neuropathy (LHON) patient-derived iPSC R.I...
https://www.senju.co.jp/rd/society/ -
Publications | Research & Development | SENJU Pharmaceutica
愛媛大学医学部眼科学教室 2)千寿製薬株式会社 3)日野病院 あたらしい眼科42(12)：1566～1576 Efficacy and Safety of SJP-0132 in Patients with Dry Eye Disease: A Phase 2b Randomized, Double-Masked, Dose-Finding Study Yuichi Hori1, Tomoyuk...
http://www.senju.co.jp/english/rd/thesis/